Federal Register: August 2, 2007 (Volume 72, Number 148)
DOCID: fr02au07-58 FR Doc E7-15030
DEPARTMENT OF COMMERCE
Foreign-Trade Zones Board
DOCUMENT ID: [T-3-2007]
NOTICE: NOTICES
DOCID: fr02au07-58
ACTION: Applications, hearings, determinations, etc.:
SUBJECT CATEGORY:
Foreign-Trade Zone 7--Mayaguez, PR; Temporary/Interim Manufacturing Authority Merck Sharpe & Dohme Quimica De Puerto Rico Inc. (Pharmaceutical Manufacturing); Notice of Approval
DOCUMENT SUMMARY:
On May 10, 2007, the Executive Secretary of the ForeignTrade Zones (FTZ) Board filed an application submitted by the Puerto Rico Industrial Development Company, grantee of FTZ 7, requesting temporary/ interim manufacturing (T/IM) authority on behalf of Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., within FTZ 7, at the MOVA Pharmaceutical Corporation pharmaceutical manufacturing facility located in Caguas, Puerto Rico.
The application was processed in accordance with T/IM procedures,
as authorized by FTZ Board Orders 1347 (69 FR 52587, 8/30/04) and 1480
(71 FR 55422, 9/22/06), including notice in the Federal Register
inviting public comment (72 FR 27801, 5/17/07). The FTZ staff examiner
reviewed the application and determined that it meets the criteria for
approval under T/IM procedures. Pursuant to the authority delegated to
the FTZ Board Executive Secretary in Board Orders 1347 and 1480 the
application was approved, effective July 23, 2007, until July 23, 2009,
subject to the FTZ Act and the Board's regulations, including Section 400.28.
Dated: July 23, 2007.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E715030 Filed 8107; 8:45 am]
BILLING CODE 3510DSP
SUMMARY:
Puerto Rico; Merck Sharpe & Dohme Quimica De Puerto Rico, Inc.; pharmaceutical manufacturing facility,
DOCUMENT BODY 2:
On May 10, 2007, the Executive Secretary of the ForeignTrade Zones (FTZ) Board filed an application submitted by the Puerto Rico Industrial Development Company, grantee of FTZ 7, requesting temporary/ interim manufacturing (T/IM) authority on behalf of Merck Sharpe & Dohme Quimica De Puerto Rico, Inc., within FTZ 7, at the MOVA Pharmaceutical Corporation pharmaceutical manufacturing facility located in Caguas, Puerto Rico.
The application was processed in accordance with T/IM procedures,
as authorized by FTZ Board Orders 1347 (69 FR 52587, 8/30/04) and 1480
(71 FR 55422, 9/22/06), including notice in the Federal Register
inviting public comment (72 FR 27801, 5/17/07). The FTZ staff examiner
reviewed the application and determined that it meets the criteria for
approval under T/IM procedures. Pursuant to the authority delegated to
the FTZ Board Executive Secretary in Board Orders 1347 and 1480 the
application was approved, effective July 23, 2007, until July 23, 2009,
subject to the FTZ Act and the Board's regulations, including Section 400.28.
Dated: July 23, 2007.
Andrew McGilvray,
Executive Secretary.
[FR Doc. E715030 Filed 8107; 8:45 am]
BILLING CODE 3510DSP